USANA Health Sciences Inc (USNA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, USANA Health Sciences Inc (USNA) has a cash flow conversion efficiency ratio of 0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($9.76 Million) by net assets ($594.79 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See USANA Health Sciences Inc (USNA) liquidity interval to measure how many days the company can operate on defensive assets alone.
USANA Health Sciences Inc - Cash Flow Conversion Efficiency Trend (1995–2025)
This chart illustrates how USANA Health Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
USANA Health Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of USANA Health Sciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangsu Smartwin Electronics Technology Co.Ltd.
SHE:301106
|
N/A |
|
Eastern Pioneer Auto Driving S
SHG:603377
|
0.177x |
|
Alantra Partners S.A.
MC:ALNT
|
0.017x |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
0.046x |
|
GuangZhou Wahlap Technology Corporation Limited
SHE:301011
|
0.043x |
|
Airsculpt Technologies Inc
NASDAQ:AIRS
|
0.053x |
|
Aekyung Petrochemical Co Ltd
KO:161000
|
0.038x |
|
Suzhou Yangtze New Materials
SHE:002652
|
0.025x |
Annual Cash Flow Conversion Efficiency for USANA Health Sciences Inc (1995–2025)
The table below shows the annual cash flow conversion efficiency of USANA Health Sciences Inc from 1995 to 2025. For the full company profile with market capitalisation and key ratios, see USANA Health Sciences Inc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $586.27 Million | $22.35 Million | 0.038x | -63.35% |
| 2024-12-31 | $586.33 Million | $60.99 Million | 0.104x | -26.78% |
| 2023-12-31 | $497.20 Million | $70.64 Million | 0.142x | -40.59% |
| 2022-12-31 | $434.47 Million | $103.90 Million | 0.239x | -22.05% |
| 2021-12-31 | $395.12 Million | $121.23 Million | 0.307x | -15.52% |
| 2020-12-31 | $441.65 Million | $160.40 Million | 0.363x | +0.79% |
| 2019-12-31 | $351.71 Million | $126.73 Million | 0.360x | -7.35% |
| 2018-12-31 | $391.15 Million | $152.12 Million | 0.389x | +14.11% |
| 2017-12-31 | $363.21 Million | $123.78 Million | 0.341x | -19.10% |
| 2016-12-31 | $325.29 Million | $137.03 Million | 0.421x | +6.14% |
| 2015-12-31 | $280.85 Million | $111.47 Million | 0.397x | -13.15% |
| 2014-12-31 | $230.16 Million | $105.19 Million | 0.457x | +20.39% |
| 2013-12-31 | $260.52 Million | $98.89 Million | 0.380x | -24.10% |
| 2012-12-31 | $185.57 Million | $92.81 Million | 0.500x | +24.06% |
| 2011-12-31 | $173.91 Million | $70.11 Million | 0.403x | -11.48% |
| 2010-12-31 | $145.17 Million | $66.11 Million | 0.455x | +4.31% |
| 2009-12-31 | $74.37 Million | $32.47 Million | 0.437x | -69.76% |
| 2008-12-31 | $31.84 Million | $45.96 Million | 1.444x | -2.52% |
| 2007-12-31 | $38.64 Million | $57.22 Million | 1.481x | +47.30% |
| 2006-12-31 | $60.20 Million | $60.52 Million | 1.005x | -4.24% |
| 2005-12-31 | $45.74 Million | $48.02 Million | 1.050x | +31.55% |
| 2004-12-31 | $47.84 Million | $38.18 Million | 0.798x | -0.19% |
| 2003-12-31 | $44.37 Million | $35.48 Million | 0.800x | -9.26% |
| 2002-12-31 | $18.09 Million | $15.94 Million | 0.881x | +28.64% |
| 2001-12-31 | $14.53 Million | $9.95 Million | 0.685x | +116.77% |
| 2000-12-31 | $12.87 Million | $4.07 Million | 0.316x | -72.82% |
| 1999-12-31 | $12.90 Million | $15.00 Million | 1.163x | +235.67% |
| 1998-12-31 | $30.60 Million | $10.60 Million | 0.346x | -5.84% |
| 1997-12-31 | $19.30 Million | $7.10 Million | 0.368x | +8.61% |
| 1996-12-31 | $12.40 Million | $4.20 Million | 0.339x | -42.68% |
| 1995-12-31 | $6.60 Million | $3.90 Million | 0.591x | -- |
About USANA Health Sciences Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Ess… Read more